A two-part series on the technical and strategic considerations, and the legal and regulatory challenges of medical product name development Presented by Brand Institute & Drug Safety Institute, a Subsidiary of Brand Institute
January 27 – The Science Behind Non Proprietary (Generic) Drug Naming with Sophia Fuerst